University of California, San Farncisco
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Seitzman, Gerami
ORBS, NCT05296837: Ocular Rosacea Biome Study

Recruiting
4
50
US
Doxycycline 40 MG ( 20mg twice daily), Doxycycline 200 MG ( 100 mg twice daily), Placebo
University of California, San Francisco
Ocular Rosacea, Antimicrobial Resistance
10/25
12/25
PUTT, NCT06213649: Parasitic Ulcer Treatment Trial

Recruiting
3
232
Europe, US, RoW
Polyhexamethylene biguanide (PHMB), Polyhexanide, Topical corticosteroid, Topical placebo
Jeremy Keenan, MD, MPH, Johns Hopkins University, Oregon Health and Science University, University of Illinois at Chicago, University of Michigan, University of California, Los Angeles, University of Pittsburgh, University of Pennsylvania, Columbia University, University of Iowa, University of Florida, Aravind Eye Care System, Moorfields Eye Hospital NHS Foundation Trust, Federal University of São Paulo, National Eye Institute (NEI)
Acanthamoeba Keratitis
07/28
07/28
SCUT II, NCT04097730: Steroids and Cross-linking for Ulcer Treatment

Completed
3
280
US, RoW
Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin Ophthalmic, Corneal Cross-Linking with Riboflavin Ophthalmic, Topical Placebo
Thomas M. Lietman, Aravind Eye Care System, National Eye Institute (NEI), University of Miami, Stanford University
Keratitis Bacterial
05/24
09/24
FANCY, NCT06658002: Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Not yet recruiting
3
150
US, RoW
Cyclosporine A, Placebo Comparator: Placebo
University of California, San Francisco, Aravind Eye Hospitals, India, Aravind Eye Care System
Fungal Keratitis, Corneal Ulcer
01/27
01/27

Download Options